22 May 2013
Keywords: santhera, raises, 9m, swfr, ares, life, sciences
Article | 10 November 2008
Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on neuromuscular diseases, says that it has raised gross
proceeds of 15.9 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 November 2008
© 2013 thepharmaletter.com